EP3693476
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.2.2013:
18.10.2023:
20154250.3
:
21.2.2033
:
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
22.2.2013
18.10.2023
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
CONG, Feng:
Cambridge, MA 02139, US
:
HAO, Huaixiang:
Cambridge, MA 02139, US
:
HSIEH, Hsin-i:
San Diego, CA 92121, US
:
LIU, Jun:
San Diego, CA 92121, US
:
NG, Nicholas:
San Diego, CA 92121, US
:
JIANG, Xiaomo:
Cambridge, MA 02139, US
:
201261604290 P:
28.2.2012:
US
:
C12Q 1/6886